Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study.

"Declarations Conflict of interestThe authors declare that they have no conflicts of interest. Ethics approval (include appropriate approvals or waivers)The study was approved by the Ethics Committee of the intervening institutions (243–18 (213-DEFI/212-CES)). Consent to participateAll participants provided written informed consent to participate in the study, as well as for the publication. Consent for publicationAll authors had access to the study data and approved the final manuscript. Conflict of interest The authors declare that they have no conflicts of interest."

"Funding There is no funding to declare."

"The study was approved by the ethics committees of the intervening institutions and was registered at ClinicalTrials.gov with the identifier NCT04188171."